BSTG Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 jul 2023 @ 21:14):

Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways...

Stats
Dagens volum	4 533.00
Gjennomsnittsvolum	972.00
Markedsverdi	57.82M
EPS	$0 ( 2024-03-28 )
Neste inntjeningsdato	( $0 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.20
ATR14	$0.130 (3.29%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-11	He Junli	Buy	220 640	Stock Option (right to buy)
2023-12-27	He Junli	Buy	2 700	Common Stock
2023-12-14	He Junli	Buy	900	Common Stock
2023-12-06	He Junli	Buy	1 500	Common Stock
2023-09-11	He Junli	Buy	1 500	Common Stock

INSIDER POWER
78.36
Last 94 transactions
Buy: 5 930 750 \| Sell: 1 021 989

Volum Korrelasjon

Lang: 0.03 (neutral)

Kort: 0.00 (neutral)

Signal:(37.812) Neutral

Biostage, Inc. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Biostage, Inc. Korrelasjon - Valuta/Råvare

-0.26
( neutral )

-0.79
( moderate negative )

-0.07
( neutral )

-0.11
( neutral )

0.88
( strong )

Biostage, Inc. Økonomi

Annual	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-1.090

FY	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-1.090

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.907

FY	2020
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.550

Financial Reports:

No articles found.

Biostage, Inc.

Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company is engaged in developing Biostage Esophageal Implant for the treating esophageal cancer. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.